Moonlake Immunotherapeutics · NASDAQ:MLTX

Bodenstedt Matthias sold 13,653 Moonlake Immunotherapeutics shares (Form 4)

Traded May 11, 2026 · Filed May 13, 2026

On May 11, 2026, Bodenstedt Matthias (Chief Financial Officer) sold 13,653 Moonlake Immunotherapeutics shares at US$20.02 for US$273K under a trading plan, leaving 1,172,431 shares. Filed May 13, 2026 (Form 4).

Sold
13,653 shares
Price
US$20.02
Value
US$273K
Holding after
1,172,431 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 11, 2026Class A ordinary shares, par value $0.0001 per shareSale13,653US$20.021,172,431Direct

Source

View original at SEC

Related